Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
NNC9204-1177 A/mL · 1 trial · 2 indications
Count of events
| Arm | Type | Description |
|---|---|---|
| NNC9204-1177 | EXPERIMENTAL | Dose trial with a sequential trial design |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| NNC9204-1177 A 1.0 mg/mL | DRUG | Participants will get 1 or more injections into the skin of the stomach area once each week for 12 weeks. Dose gradually increased to 6000 μg. |
| PLACEBO | DRUG | Participants will get 1 or more injections into the skin of the stomach area once each week for 12 weeks. |
Inclusion Criteria: * Male or female, aged 18-55 years (both inclusive) at the time of signing informed consent * Body mass index (BMI) between 27.0 and 39.9 kg/m2 (both inclusive) at screening. Overweight should be due to excess adipose tissue, as judged by the investigator Exclusion Criteria: *...
NNC9204-1177 A/mL is an investigational small molecule being developed for metabolism and nutrition disorders, specifically for weight management in people with overweight or obesity. It is being studied as a potential treatment to address these metabolic conditions.
NNC9204-1177 A/mL is being developed by Novo Nordisk A/S, a pharmaceutical company listed on the stock exchange under the ticker NVO. The company is conducting clinical research to evaluate the drug's safety and efficacy.
NNC9204-1177 A/mL is in Phase 1 clinical development. It is an investigational drug, meaning it has not been approved by regulatory authorities and is still undergoing clinical trials to assess its safety and effectiveness.
NNC9204-1177 A/mL has one completed clinical trial, identified as NCT03308721. This Phase 1 study was a randomized, double-blind, placebo-controlled trial conducted in the United States, enrolling 99 participants with overweight or obesity.
NNC9204-1177 A/mL is a formulation of the drug NNC9204-1177. The clinical trial NCT03308721 refers to the study medicine as NNC9204-1177, and the A/mL designation indicates a specific concentration or formulation used in the research.